Sign In

Login

Password

Forgot Password ? Sign Up

DRD4 (French Wikipedia)

Analysis of information sources in references of the Wikipedia article "DRD4" in French language version.

refsWebsite
Global rank French rank
55nih.gov
4th place
12th place
53doi.org
2nd place
3rd place
24semanticscholar.org
11th place
325th place
4harvard.edu
18th place
118th place
3aspetjournals.org
6,663rd place
5,973rd place
1psu.edu
207th place
929th place
1escholarship.org
1,523rd place
2,842nd place
1zenodo.org
621st place
3,834th place
1handle.net
102nd place
779th place

aspetjournals.org

jpet.aspetjournals.org

  • « Biological profile of L-745,870, a selective antagonist with high affinity for the dopamine D4 receptor », The Journal of Pharmacology and Experimental Therapeutics, vol. 283, no 2,‎ , p. 636–47 (PMID 9353380, lire en ligne)
  • « S 18126 ([2-[4-(2,3-dihydrobenzo[1,4]dioxin-6-yl)piperazin-1-yl methyl]indan-2-yl]), a potent, selective and competitive antagonist at dopamine D4 receptors: an in vitro and in vivo comparison with L 745,870 (3-(4-[4-chlorophenyl]piperazin-1-yl)methyl-1H-pyrrolo[2, 3b]pyridine) and raclopride », The Journal of Pharmacology and Experimental Therapeutics, vol. 287, no 1,‎ , p. 167–86 (PMID 9765336, lire en ligne)

molpharm.aspetjournals.org

  • « Identification and pharmacological characterization of [125I]L-750,667, a novel radioligand for the dopamine D4 receptor », Molecular Pharmacology, vol. 50, no 6,‎ , p. 1658–64 (PMID 8967990, lire en ligne)

doi.org

dx.doi.org

  • « Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine », Nature, vol. 350, no 6319,‎ , p. 610–4 (PMID 1840645, DOI 10.1038/350610a0, Bibcode 1991Natur.350..610V, S2CID 4244670)
  • « D4 dopamine receptor high-resolution structures enable the discovery of selective agonists », Science, vol. 358, no 6361,‎ , p. 381–386 (PMID 29051383, PMCID 5856174, DOI 10.1126/science.aan5468, Bibcode 2017Sci...358..381W)
  • « Dopamine D4 receptor gene DRD4 and its association with psychiatric disorders », Medical Science Monitor, vol. 17, no 9,‎ , RA215–20 (PMID 21873960, PMCID 3560519, DOI 10.12659/MSM.881925)
  • « Clinical and molecular genetics of psychotic depression », Schizophrenia Bulletin, vol. 39, no 4,‎ , p. 766–75 (PMID 23512949, PMCID 3686457, DOI 10.1093/schbul/sbt040)
  • « Evidence that the dopamine D4 receptor is a susceptibility gene in attention deficit hyperactivity disorder », Molecular Psychiatry, vol. 3, no 5,‎ , p. 427–30 (PMID 9774776, DOI 10.1038/sj.mp.4000457)
  • « The DRD4 exon 3 VNTR polymorphism and addiction-related phenotypes: a review », Pharmacology Biochemistry and Behavior, vol. 93, no 3,‎ , p. 222–9 (PMID 19336242, PMCID 2706302, DOI 10.1016/j.pbb.2009.03.010)
  • « Genetics of impulse control disorders in Parkinson's disease », Journal of Neural Transmission, vol. 120, no 4,‎ , p. 665–71 (PMID 23232665, DOI 10.1007/s00702-012-0934-4, S2CID 21967333)
  • « Molecular mechanisms underlying anorexia nervosa: focus on human gene association studies and systems controlling food intake », Brain Research Reviews, vol. 62, no 2,‎ , p. 147–64 (PMID 19931559, DOI 10.1016/j.brainresrev.2009.10.007, S2CID 37635456)
  • « Targeted D4 dopamine receptors: implications for drug discovery and therapeutic development », Current Drug Targets, vol. 14, no 4,‎ , p. 507–12 (PMID 23469923, DOI 10.2174/1389450111314040012)
  • « Dopamine receptor signaling », Journal of Receptor and Signal Transduction Research, vol. 24, no 3,‎ , p. 165–205 (PMID 15521361, DOI 10.1081/RRS-200029981, S2CID 12407397, CiteSeerx 10.1.1.465.5011)
  • « Multiple dopamine D4 receptor variants in the human population », Nature, vol. 358, no 6382,‎ , p. 149–52 (PMID 1319557, DOI 10.1038/358149a0, Bibcode 1992Natur.358..149T, S2CID 4345839)
  • « Distribution of a novel mutation in the first exon of the human dopamine D4 receptor gene in psychotic patients », Biological Psychiatry, vol. 34, no 7,‎ , p. 459–64 (PMID 8268330, DOI 10.1016/0006-3223(93)90236-7, S2CID 34841647)
  • « The dopamine D4 receptor: biochemical and signalling properties », Cellular and Molecular Life Sciences, vol. 67, no 12,‎ , p. 1971–86 (PMID 20165900, DOI 10.1007/s00018-010-0293-y, S2CID 21432517)
  • « Advances in genetic findings on attention deficit hyperactivity disorder », Psychological Medicine, vol. 37, no 12,‎ , p. 1681–92 (PMID 17506925, DOI 10.1017/S0033291707000773, S2CID 20556855)
  • « Association of the dopamine D4 receptor (DRD4) gene and approach-related personality traits: meta-analysis and new data », Biological Psychiatry, vol. 63, no 2,‎ , p. 197–206 (PMID 17574217, DOI 10.1016/j.biopsych.2007.04.006, S2CID 28997438)
  • « Functional activation by central monoamines of human dopamine D(4) receptor polymorphic variants coupled to GIRK channels in Xenopus oocytes », European Journal of Pharmacology, vol. 562, no 3,‎ , p. 165–73 (PMID 17350612, DOI 10.1016/j.ejphar.2007.01.055)
  • « Role of dopamine receptors in ADHD: a systematic meta-analysis », Molecular Neurobiology, vol. 45, no 3,‎ , p. 605–20 (PMID 22610946, DOI 10.1007/s12035-012-8278-5, S2CID 895006)
  • « Meta-analysis of the association between the 7-repeat allele of the dopamine D(4) receptor gene and attention deficit hyperactivity disorder », The American Journal of Psychiatry, vol. 158, no 7,‎ , p. 1052–7 (PMID 11431226, DOI 10.1176/appi.ajp.158.7.1052)
  • « Abnormal early stages of task stimulus processing in children with attention-deficit hyperactivity disorder--evidence from event-related gamma oscillations », Clinical Neurophysiology, vol. 112, no 6,‎ , p. 1096–108 (PMID 11377270, DOI 10.1016/s1388-2457(01)00524-7, S2CID 19789570)
  • « DRD4 and DAT1 polymorphisms modulate human gamma band responses », Cerebral Cortex, vol. 17, no 5,‎ , p. 1007–19 (PMID 16751296, DOI 10.1093/cercor/bhl011)
  • « The genetic architecture of selection at the human dopamine receptor D4 (DRD4) gene locus », American Journal of Human Genetics, vol. 74, no 5,‎ , p. 931–44 (PMID 15077199, PMCID 1181986, DOI 10.1086/420854)
  • « Modulation of intracellular cyclic AMP levels by different human dopamine D4 receptor variants », Journal of Neurochemistry, vol. 65, no 3,‎ , p. 1157–65 (PMID 7643093, DOI 10.1046/j.1471-4159.1995.65031157.x, S2CID 23092115)
  • « Population Migration and the Variation of Dopamine D4 Receptor (DRD4) Allele Frequencies Around the Globe », Evolution and Human Behavior, vol. 20, no 5,‎ , p. 309–24 (DOI 10.1016/S1090-5138(99)00015-X, S2CID 12754148, lire en ligne)
  • « Dopamine receptor genetic polymorphisms and body composition in undernourished pastoralists: an exploration of nutrition indices among nomadic and recently settled Ariaal men of northern Kenya », BMC Evolutionary Biology, vol. 8,‎ , p. 173 (PMID 18544160, PMCID 2440754, DOI 10.1186/1471-2148-8-173)
  • « Dopamine D4 receptor (D4DR) exon III polymorphism associated with the human personality trait of Novelty Seeking », Nature Genetics, vol. 12, no 1,‎ , p. 78–80 (PMID 8528256, DOI 10.1038/ng0196-78, S2CID 27276401)
  • « Population and familial association between the D4 dopamine receptor gene and measures of Novelty Seeking », Nature Genetics, vol. 12, no 1,‎ , p. 81–4 (PMID 8528258, DOI 10.1038/ng0196-81, S2CID 24226671, lire en ligne)
  • « Drd4 gene polymorphisms are associated with personality variation in a passerine bird », Proceedings: Biological Sciences, vol. 274, no 1619,‎ , p. 1685–91 (PMID 17472912, PMCID 1914334, DOI 10.1098/rspb.2007.0337)
  • « Behaviour-related DRD4 polymorphisms in invasive bird populations », Molecular Ecology, vol. 23, no 11,‎ , p. 2876–85 (PMID 24750181, DOI 10.1111/mec.12763, hdl 10261/101638, S2CID 10576133)
  • « Polymorphisms of the Dopamine D4 Receptor Gene in Stabled Horses are Related to Differences in Behavioral Response to Frustration », Animals, vol. 3, no 3,‎ , p. 663–9 (PMID 26479526, PMCID 4494454, DOI 10.3390/ani3030663)
  • « Breed Differences in Dopamine Receptor D4 Gene (DRD4) in Horses », Journal of Equine Science, vol. 24, no 3,‎ , p. 31–6 (PMID 24833999, PMCID 4013985, DOI 10.1294/jes.24.31)
  • « Association of polymorphisms in the dopamine D4 receptor gene and the activity-impulsivity endophenotype in dogs », Animal Genetics, vol. 38, no 6,‎ , p. 629–33 (PMID 17986156, DOI 10.1111/j.1365-2052.2007.01657.x)
  • Timm, K., Mägi, M., Telva, K. et Tilgar, V., « The behavioural response of Great Tits to novel environment and handling is affected by the DRD4 gene », Ibis, vol. 161, no 2,‎ , p. 91–100 (DOI 10.1111/ibi.12604)
  • « Control networks and neuromodulators of early development », Developmental Psychology, vol. 48, no 3,‎ , p. 827–35 (PMID 21942663, PMCID 3253251, DOI 10.1037/a0025530)
  • « Facilitatory effect of the dopamine D4 receptor agonist PD168,077 on memory consolidation of an inhibitory avoidance learned response in C57BL/6J mice », Behavioural Brain Research, vol. 142, nos 1–2,‎ , p. 41–52 (PMID 12798264, DOI 10.1016/s0166-4328(02)00371-6, S2CID 21960608)
  • « A-412997, a selective dopamine D4 agonist, improves cognitive performance in rats », Pharmacology Biochemistry and Behavior, vol. 82, no 1,‎ , p. 148–55 (PMID 16154186, DOI 10.1016/j.pbb.2005.08.002, S2CID 31796938)
  • « Selective dopamine D4 receptor agonist (A-412997) improves cognitive performance and stimulates motor activity without influencing reward-related behaviour in rat », Behavioural Pharmacology, vol. 19, no 8,‎ , p. 765–76 (PMID 19020411, DOI 10.1097/FBP.0b013e32831c3b06, S2CID 36272297)
  • « Dopamine D4 receptor antagonist reversal of subchronic phencyclidine-induced object retrieval/detour deficits in monkeys », Psychopharmacology, vol. 142, no 1,‎ , p. 78–84 (PMID 10102786, DOI 10.1007/s002130050865, S2CID 24469748)
  • « The selective dopamine D4 receptor antagonist, PNU-101387G, prevents stress-induced cognitive deficits in monkeys », Neuropsychopharmacology, vol. 23, no 4,‎ , p. 405–10 (PMID 10989267, DOI 10.1016/S0893-133X(00)00133-0)
  • « Neuronal correlates of ketamine and walking induced gamma oscillations in the medial prefrontal cortex and mediodorsal thalamus », PLOS ONE, vol. 12, no 11,‎ , e0186732 (PMID 29095852, PMCID 5667758, DOI 10.1371/journal.pone.0186732, Bibcode 2017PLoSO..1286732F)
  • « Enhancement of gamma activity after selective activation of dopamine D4 receptors in freely moving rats and in a neurodevelopmental model of schizophrenia », Brain Structure & Function, vol. 219, no 6,‎ , p. 2173–80 (PMID 23839116, PMCID 3859720, DOI 10.1007/s00429-013-0607-6)
  • « Behavioral and neurophysiological effects of Ro 10-5824, a dopamine D4 receptor partial agonist, in common marmosets », Psychopharmacology, vol. 232, no 17,‎ , p. 3287–95 (PMID 26041337, DOI 10.1007/s00213-015-3978-y, S2CID 17141380)
  • « WAY-100635 is a potent dopamine D4 receptor agonist », Psychopharmacology, vol. 188, no 2,‎ , p. 244–51 (PMID 16915381, DOI 10.1007/s00213-006-0490-4, S2CID 24194034)
  • « A-412997 is a selective dopamine D4 receptor agonist in rats », Pharmacology Biochemistry and Behavior, vol. 82, no 1,‎ , p. 140–7 (PMID 16153699, DOI 10.1016/j.pbb.2005.08.001, S2CID 10270715)
  • « Discovery of 2-(4-pyridin-2-ylpiperazin-1-ylmethyl)-1H-benzimidazole (ABT-724), a dopaminergic agent with a novel mode of action for the potential treatment of erectile dysfunction », Journal of Medicinal Chemistry, vol. 47, no 15,‎ , p. 3853–64 (PMID 15239663, DOI 10.1021/jm030505a)
  • « Discovery of 3-methyl-N-(1-oxy-3',4',5',6'-tetrahydro-2'H-[2,4'-bipyridine]-1'-ylmethyl)benzamide (ABT-670), an orally bioavailable dopamine D4 agonist for the treatment of erectile dysfunction », Journal of Medicinal Chemistry, vol. 49, no 25,‎ , p. 7450–65 (PMID 17149874, DOI 10.1021/jm060662k)
  • « Cyanoindole derivatives as highly selective dopamine D(4) receptor partial agonists: solid-phase synthesis, binding assays, and functional experiments », Journal of Medicinal Chemistry, vol. 43, no 23,‎ , p. 4563–9 (PMID 11087581, DOI 10.1021/jm0009989)
  • « 1-aryl-3-(4-pyridine-2-ylpiperazin-1-yl)propan-1-one oximes as potent dopamine D4 receptor agonists for the treatment of erectile dysfunction », Journal of Medicinal Chemistry, vol. 49, no 17,‎ , p. 5093–109 (PMID 16913699, DOI 10.1021/jm060279f)
  • « 2-[(4-phenylpiperazin-1-yl)methyl]imidazo(di)azines as selective D4-ligands. Induction of penile erection by 2-[4-(2-methoxyphenyl)piperazin-1-ylmethyl]imidazo[1,2-a]pyridine (PIP3EA), a potent and selective D4 partial agonist », Journal of Medicinal Chemistry, vol. 49, no 13,‎ , p. 3938–47 (PMID 16789750, DOI 10.1021/jm060166w)
  • « 2-[4-(3,4-Dimethylphenyl)piperazin-1-ylmethyl]-1H benzoimidazole (A-381393), a selective dopamine D4 receptor antagonist », Neuropharmacology, vol. 49, no 1,‎ , p. 112–21 (PMID 15992586, DOI 10.1016/j.neuropharm.2005.02.004, S2CID 7529599)
  • « Synthesis, radiofluorination, and in vitro evaluation of pyrazolo[1,5-a]pyridine-based dopamine D4 receptor ligands: discovery of an inverse agonist radioligand for PET », Journal of Medicinal Chemistry, vol. 51, no 6,‎ , p. 1800–10 (PMID 18307287, DOI 10.1021/jm701375u)
  • « 3-((4-(4-Chlorophenyl)piperazin-1-yl)-methyl)-1H-pyrrolo-2,3-b-pyridine: an antagonist with high affinity and selectivity for the human dopamine D4 receptor », Journal of Medicinal Chemistry, vol. 39, no 10,‎ , p. 1941–2 (PMID 8642550, DOI 10.1021/jm9600712)
  • « Discovery and Characterization of ML398, a Potent and Selective Antagonist of the D4 Receptor with in Vivo Activity », ACS Medicinal Chemistry Letters, vol. 5, no 9,‎ , p. 1060–4 (PMID 25221667, PMCID 4160761, DOI 10.1021/ml500267c)
  • « Comparative molecular field analysis of dopamine D4 receptor antagonists including 3-[4-(4-chlorophenyl)piperazin-1-ylmethyl]pyrazolo[1,5-a]pyridine (FAUC 113), 3-[4-(4-chlorophenyl)piperazin-1-ylmethyl]-1H-pyrrolo-[2,3-b]pyridine (L-745,870), and clozapine », Journal of Medicinal Chemistry, vol. 44, no 8,‎ , p. 1151–7 (PMID 11312915, DOI 10.1021/jm001055e)

escholarship.org

handle.net

hdl.handle.net

harvard.edu

ui.adsabs.harvard.edu

nih.gov

ncbi.nlm.nih.gov

  • « Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine », Nature, vol. 350, no 6319,‎ , p. 610–4 (PMID 1840645, DOI 10.1038/350610a0, Bibcode 1991Natur.350..610V, S2CID 4244670)
  • « D4 dopamine receptor high-resolution structures enable the discovery of selective agonists », Science, vol. 358, no 6361,‎ , p. 381–386 (PMID 29051383, PMCID 5856174, DOI 10.1126/science.aan5468, Bibcode 2017Sci...358..381W)
  • « Dopamine D4 receptor gene DRD4 and its association with psychiatric disorders », Medical Science Monitor, vol. 17, no 9,‎ , RA215–20 (PMID 21873960, PMCID 3560519, DOI 10.12659/MSM.881925)
  • « Clinical and molecular genetics of psychotic depression », Schizophrenia Bulletin, vol. 39, no 4,‎ , p. 766–75 (PMID 23512949, PMCID 3686457, DOI 10.1093/schbul/sbt040)
  • « Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder », Molecular Psychiatry, vol. 1, no 2,‎ , p. 121–4 (PMID 9118321)
  • « Evidence that the dopamine D4 receptor is a susceptibility gene in attention deficit hyperactivity disorder », Molecular Psychiatry, vol. 3, no 5,‎ , p. 427–30 (PMID 9774776, DOI 10.1038/sj.mp.4000457)
  • « The DRD4 exon 3 VNTR polymorphism and addiction-related phenotypes: a review », Pharmacology Biochemistry and Behavior, vol. 93, no 3,‎ , p. 222–9 (PMID 19336242, PMCID 2706302, DOI 10.1016/j.pbb.2009.03.010)
  • « Genetics of impulse control disorders in Parkinson's disease », Journal of Neural Transmission, vol. 120, no 4,‎ , p. 665–71 (PMID 23232665, DOI 10.1007/s00702-012-0934-4, S2CID 21967333)
  • « Molecular mechanisms underlying anorexia nervosa: focus on human gene association studies and systems controlling food intake », Brain Research Reviews, vol. 62, no 2,‎ , p. 147–64 (PMID 19931559, DOI 10.1016/j.brainresrev.2009.10.007, S2CID 37635456)
  • « Targeted D4 dopamine receptors: implications for drug discovery and therapeutic development », Current Drug Targets, vol. 14, no 4,‎ , p. 507–12 (PMID 23469923, DOI 10.2174/1389450111314040012)
  • « Dopamine receptor signaling », Journal of Receptor and Signal Transduction Research, vol. 24, no 3,‎ , p. 165–205 (PMID 15521361, DOI 10.1081/RRS-200029981, S2CID 12407397, CiteSeerx 10.1.1.465.5011)
  • « Multiple dopamine D4 receptor variants in the human population », Nature, vol. 358, no 6382,‎ , p. 149–52 (PMID 1319557, DOI 10.1038/358149a0, Bibcode 1992Natur.358..149T, S2CID 4345839)
  • « Distribution of a novel mutation in the first exon of the human dopamine D4 receptor gene in psychotic patients », Biological Psychiatry, vol. 34, no 7,‎ , p. 459–64 (PMID 8268330, DOI 10.1016/0006-3223(93)90236-7, S2CID 34841647)
  • « The dopamine D4 receptor: biochemical and signalling properties », Cellular and Molecular Life Sciences, vol. 67, no 12,‎ , p. 1971–86 (PMID 20165900, DOI 10.1007/s00018-010-0293-y, S2CID 21432517)
  • « Advances in genetic findings on attention deficit hyperactivity disorder », Psychological Medicine, vol. 37, no 12,‎ , p. 1681–92 (PMID 17506925, DOI 10.1017/S0033291707000773, S2CID 20556855)
  • « Association of the dopamine D4 receptor (DRD4) gene and approach-related personality traits: meta-analysis and new data », Biological Psychiatry, vol. 63, no 2,‎ , p. 197–206 (PMID 17574217, DOI 10.1016/j.biopsych.2007.04.006, S2CID 28997438)
  • « Functional activation by central monoamines of human dopamine D(4) receptor polymorphic variants coupled to GIRK channels in Xenopus oocytes », European Journal of Pharmacology, vol. 562, no 3,‎ , p. 165–73 (PMID 17350612, DOI 10.1016/j.ejphar.2007.01.055)
  • « Role of dopamine receptors in ADHD: a systematic meta-analysis », Molecular Neurobiology, vol. 45, no 3,‎ , p. 605–20 (PMID 22610946, DOI 10.1007/s12035-012-8278-5, S2CID 895006)
  • « Meta-analysis of the association between the 7-repeat allele of the dopamine D(4) receptor gene and attention deficit hyperactivity disorder », The American Journal of Psychiatry, vol. 158, no 7,‎ , p. 1052–7 (PMID 11431226, DOI 10.1176/appi.ajp.158.7.1052)
  • « Abnormal early stages of task stimulus processing in children with attention-deficit hyperactivity disorder--evidence from event-related gamma oscillations », Clinical Neurophysiology, vol. 112, no 6,‎ , p. 1096–108 (PMID 11377270, DOI 10.1016/s1388-2457(01)00524-7, S2CID 19789570)
  • « DRD4 and DAT1 polymorphisms modulate human gamma band responses », Cerebral Cortex, vol. 17, no 5,‎ , p. 1007–19 (PMID 16751296, DOI 10.1093/cercor/bhl011)
  • « The genetic architecture of selection at the human dopamine receptor D4 (DRD4) gene locus », American Journal of Human Genetics, vol. 74, no 5,‎ , p. 931–44 (PMID 15077199, PMCID 1181986, DOI 10.1086/420854)
  • « Modulation of intracellular cyclic AMP levels by different human dopamine D4 receptor variants », Journal of Neurochemistry, vol. 65, no 3,‎ , p. 1157–65 (PMID 7643093, DOI 10.1046/j.1471-4159.1995.65031157.x, S2CID 23092115)
  • « Dopamine receptor genetic polymorphisms and body composition in undernourished pastoralists: an exploration of nutrition indices among nomadic and recently settled Ariaal men of northern Kenya », BMC Evolutionary Biology, vol. 8,‎ , p. 173 (PMID 18544160, PMCID 2440754, DOI 10.1186/1471-2148-8-173)
  • « Dopamine D4 receptor (D4DR) exon III polymorphism associated with the human personality trait of Novelty Seeking », Nature Genetics, vol. 12, no 1,‎ , p. 78–80 (PMID 8528256, DOI 10.1038/ng0196-78, S2CID 27276401)
  • « Population and familial association between the D4 dopamine receptor gene and measures of Novelty Seeking », Nature Genetics, vol. 12, no 1,‎ , p. 81–4 (PMID 8528258, DOI 10.1038/ng0196-81, S2CID 24226671, lire en ligne)
  • « Drd4 gene polymorphisms are associated with personality variation in a passerine bird », Proceedings: Biological Sciences, vol. 274, no 1619,‎ , p. 1685–91 (PMID 17472912, PMCID 1914334, DOI 10.1098/rspb.2007.0337)
  • « Behaviour-related DRD4 polymorphisms in invasive bird populations », Molecular Ecology, vol. 23, no 11,‎ , p. 2876–85 (PMID 24750181, DOI 10.1111/mec.12763, hdl 10261/101638, S2CID 10576133)
  • « Polymorphisms of the Dopamine D4 Receptor Gene in Stabled Horses are Related to Differences in Behavioral Response to Frustration », Animals, vol. 3, no 3,‎ , p. 663–9 (PMID 26479526, PMCID 4494454, DOI 10.3390/ani3030663)
  • « Breed Differences in Dopamine Receptor D4 Gene (DRD4) in Horses », Journal of Equine Science, vol. 24, no 3,‎ , p. 31–6 (PMID 24833999, PMCID 4013985, DOI 10.1294/jes.24.31)
  • « Association of polymorphisms in the dopamine D4 receptor gene and the activity-impulsivity endophenotype in dogs », Animal Genetics, vol. 38, no 6,‎ , p. 629–33 (PMID 17986156, DOI 10.1111/j.1365-2052.2007.01657.x)
  • « Control networks and neuromodulators of early development », Developmental Psychology, vol. 48, no 3,‎ , p. 827–35 (PMID 21942663, PMCID 3253251, DOI 10.1037/a0025530)
  • « Facilitatory effect of the dopamine D4 receptor agonist PD168,077 on memory consolidation of an inhibitory avoidance learned response in C57BL/6J mice », Behavioural Brain Research, vol. 142, nos 1–2,‎ , p. 41–52 (PMID 12798264, DOI 10.1016/s0166-4328(02)00371-6, S2CID 21960608)
  • « A-412997, a selective dopamine D4 agonist, improves cognitive performance in rats », Pharmacology Biochemistry and Behavior, vol. 82, no 1,‎ , p. 148–55 (PMID 16154186, DOI 10.1016/j.pbb.2005.08.002, S2CID 31796938)
  • « Selective dopamine D4 receptor agonist (A-412997) improves cognitive performance and stimulates motor activity without influencing reward-related behaviour in rat », Behavioural Pharmacology, vol. 19, no 8,‎ , p. 765–76 (PMID 19020411, DOI 10.1097/FBP.0b013e32831c3b06, S2CID 36272297)
  • « Dopamine D4 receptor antagonist reversal of subchronic phencyclidine-induced object retrieval/detour deficits in monkeys », Psychopharmacology, vol. 142, no 1,‎ , p. 78–84 (PMID 10102786, DOI 10.1007/s002130050865, S2CID 24469748)
  • « The selective dopamine D4 receptor antagonist, PNU-101387G, prevents stress-induced cognitive deficits in monkeys », Neuropsychopharmacology, vol. 23, no 4,‎ , p. 405–10 (PMID 10989267, DOI 10.1016/S0893-133X(00)00133-0)
  • « Neuronal correlates of ketamine and walking induced gamma oscillations in the medial prefrontal cortex and mediodorsal thalamus », PLOS ONE, vol. 12, no 11,‎ , e0186732 (PMID 29095852, PMCID 5667758, DOI 10.1371/journal.pone.0186732, Bibcode 2017PLoSO..1286732F)
  • « Enhancement of gamma activity after selective activation of dopamine D4 receptors in freely moving rats and in a neurodevelopmental model of schizophrenia », Brain Structure & Function, vol. 219, no 6,‎ , p. 2173–80 (PMID 23839116, PMCID 3859720, DOI 10.1007/s00429-013-0607-6)
  • « Behavioral and neurophysiological effects of Ro 10-5824, a dopamine D4 receptor partial agonist, in common marmosets », Psychopharmacology, vol. 232, no 17,‎ , p. 3287–95 (PMID 26041337, DOI 10.1007/s00213-015-3978-y, S2CID 17141380)
  • « WAY-100635 is a potent dopamine D4 receptor agonist », Psychopharmacology, vol. 188, no 2,‎ , p. 244–51 (PMID 16915381, DOI 10.1007/s00213-006-0490-4, S2CID 24194034)
  • « A-412997 is a selective dopamine D4 receptor agonist in rats », Pharmacology Biochemistry and Behavior, vol. 82, no 1,‎ , p. 140–7 (PMID 16153699, DOI 10.1016/j.pbb.2005.08.001, S2CID 10270715)
  • « Discovery of 2-(4-pyridin-2-ylpiperazin-1-ylmethyl)-1H-benzimidazole (ABT-724), a dopaminergic agent with a novel mode of action for the potential treatment of erectile dysfunction », Journal of Medicinal Chemistry, vol. 47, no 15,‎ , p. 3853–64 (PMID 15239663, DOI 10.1021/jm030505a)
  • « Discovery of 3-methyl-N-(1-oxy-3',4',5',6'-tetrahydro-2'H-[2,4'-bipyridine]-1'-ylmethyl)benzamide (ABT-670), an orally bioavailable dopamine D4 agonist for the treatment of erectile dysfunction », Journal of Medicinal Chemistry, vol. 49, no 25,‎ , p. 7450–65 (PMID 17149874, DOI 10.1021/jm060662k)
  • « Cyanoindole derivatives as highly selective dopamine D(4) receptor partial agonists: solid-phase synthesis, binding assays, and functional experiments », Journal of Medicinal Chemistry, vol. 43, no 23,‎ , p. 4563–9 (PMID 11087581, DOI 10.1021/jm0009989)
  • « 1-aryl-3-(4-pyridine-2-ylpiperazin-1-yl)propan-1-one oximes as potent dopamine D4 receptor agonists for the treatment of erectile dysfunction », Journal of Medicinal Chemistry, vol. 49, no 17,‎ , p. 5093–109 (PMID 16913699, DOI 10.1021/jm060279f)
  • « 2-[(4-phenylpiperazin-1-yl)methyl]imidazo(di)azines as selective D4-ligands. Induction of penile erection by 2-[4-(2-methoxyphenyl)piperazin-1-ylmethyl]imidazo[1,2-a]pyridine (PIP3EA), a potent and selective D4 partial agonist », Journal of Medicinal Chemistry, vol. 49, no 13,‎ , p. 3938–47 (PMID 16789750, DOI 10.1021/jm060166w)
  • « 2-[4-(3,4-Dimethylphenyl)piperazin-1-ylmethyl]-1H benzoimidazole (A-381393), a selective dopamine D4 receptor antagonist », Neuropharmacology, vol. 49, no 1,‎ , p. 112–21 (PMID 15992586, DOI 10.1016/j.neuropharm.2005.02.004, S2CID 7529599)
  • « Synthesis, radiofluorination, and in vitro evaluation of pyrazolo[1,5-a]pyridine-based dopamine D4 receptor ligands: discovery of an inverse agonist radioligand for PET », Journal of Medicinal Chemistry, vol. 51, no 6,‎ , p. 1800–10 (PMID 18307287, DOI 10.1021/jm701375u)
  • « 3-((4-(4-Chlorophenyl)piperazin-1-yl)-methyl)-1H-pyrrolo-2,3-b-pyridine: an antagonist with high affinity and selectivity for the human dopamine D4 receptor », Journal of Medicinal Chemistry, vol. 39, no 10,‎ , p. 1941–2 (PMID 8642550, DOI 10.1021/jm9600712)
  • « Biological profile of L-745,870, a selective antagonist with high affinity for the dopamine D4 receptor », The Journal of Pharmacology and Experimental Therapeutics, vol. 283, no 2,‎ , p. 636–47 (PMID 9353380, lire en ligne)
  • « Identification and pharmacological characterization of [125I]L-750,667, a novel radioligand for the dopamine D4 receptor », Molecular Pharmacology, vol. 50, no 6,‎ , p. 1658–64 (PMID 8967990, lire en ligne)
  • « Discovery and Characterization of ML398, a Potent and Selective Antagonist of the D4 Receptor with in Vivo Activity », ACS Medicinal Chemistry Letters, vol. 5, no 9,‎ , p. 1060–4 (PMID 25221667, PMCID 4160761, DOI 10.1021/ml500267c)
  • « S 18126 ([2-[4-(2,3-dihydrobenzo[1,4]dioxin-6-yl)piperazin-1-yl methyl]indan-2-yl]), a potent, selective and competitive antagonist at dopamine D4 receptors: an in vitro and in vivo comparison with L 745,870 (3-(4-[4-chlorophenyl]piperazin-1-yl)methyl-1H-pyrrolo[2, 3b]pyridine) and raclopride », The Journal of Pharmacology and Experimental Therapeutics, vol. 287, no 1,‎ , p. 167–86 (PMID 9765336, lire en ligne)
  • « Comparative molecular field analysis of dopamine D4 receptor antagonists including 3-[4-(4-chlorophenyl)piperazin-1-ylmethyl]pyrazolo[1,5-a]pyridine (FAUC 113), 3-[4-(4-chlorophenyl)piperazin-1-ylmethyl]-1H-pyrrolo-[2,3-b]pyridine (L-745,870), and clozapine », Journal of Medicinal Chemistry, vol. 44, no 8,‎ , p. 1151–7 (PMID 11312915, DOI 10.1021/jm001055e)

psu.edu

citeseerx.ist.psu.edu

semanticscholar.org

api.semanticscholar.org

zenodo.org